Response to SARS-CoV-2 associated Guillain- Barre syndrome after awaking on the ICU: Consider differentials

References (5)

1. Koca A, Talan L, Şahin T, Güle Çınar G, Evren E, Zeynep Ceren Karahan, et al. An unusual course of SARS-CoV-2 infection: Challenging diagnosis of Guillain-Barré Syndrome. SARS-CoV-2 enfeksiyonunun olağandışı seyri: Guillain-Barré sendromunun zorlu teşhisi. Tuberk Toraks 2021; 69(2): 242-6
2. Khanlou H, Valdes-Sueiras M, Farthing C. Peripheral Neuropathy Induced by Lopinavir-Saquinavir-Ritonavir Combination Therapy in an HIV-Infected Patient. J Int Assoc Physicians AIDS Care 2007;6(3):155
3. Becerra JL, Coll-Cantí J, Gelpí-Mantius E, Ferrer-Avellí X, Lozano-Sánchez M, Millán-Torné M, et al. Miopatía y neuropatía inducida por cloroquina: tetraparesia progresiva con arreflexia que simula una polirradiculoneuropatía. A propósito de dos casos. Rev Neurol 2003; 36(06): 523-6
4. Uncini A, Kuwabara S. Electrodiagnostic criteria for Guillain–Barrè syndrome: A critical revision and the need for an update. Clin Neurophysiol 2012; 123(8): 1487-95
5. Odaka M, Yuki N, Yamada M, Koga M, Takemi T, Hirata K, et al. Bickerstaff’s brainstem encephalitis: clinical features of 62 cases and a subgroup associated with Guillain–Barré syndrome. Brain 2003; 126(10): 2279-90.